Anti-diarrheal
NDC Package 33992-0375-2
Package Information
Anti-diarrheal is see also Warning section. Marketed by Greenbrier International, Inc., this product is identified by NDC 33992-0375 and is authorized under FDA application ANDA076497.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 33992 - Greenbrier International, Inc.
- 33992-0375 - Anti-diarrheal
- 33992-0375-2 - 2 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK
- 33992-0375 - Anti-diarrheal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (33992-0375). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 33992-0375-2 identifies a specific commercial package of 2 blister pack in 1 carton / 6 tablet in 1 blister pack of Anti-diarrheal, labeled by Greenbrier International, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Greenbrier International, Inc. on May 03, 2005. The current certification is valid through October 21, 2023.
What are the primary indications for this medication?
See also Warning section. This medication is used to treat sudden diarrhea (including traveler's diarrhea). It works by slowing down the movement of the gut. This decreases the number of bowel movements and makes the stool less watery. Loperamide is also used to reduce the amount of discharge in patients who have had an ileostomy. It is also used to treat ongoing diarrhea in people with inflammatory bowel disease. Loperamide treats only the symptoms, not the cause of the diarrhea (e.g., infection). Treatment of other symptoms and the cause of the diarrhea should be determined by your doctor.
How is this Greenbrier International, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 33992037502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.